Download DNB 2019 June MICROBIOLOGY MICROBIOLOGY PAPER 2 Question Paper

Download Diplomate in National Board (DNB) 2019 June MICROBIOLOGY MICROBIOLOGY PAPER 2 Previous Question Papers

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2019
MICROBIOLOGY
PAPER-Il
Time: 3 hours MICRO/J/19/18/II
Max. Marksz100
Important Instructions:
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/f/owcharts wherever appropriate.
Write short notes on:
1 .
10.
POSSESSION/USE OF CELL PHONES 0R AN Y S UCH ELECTRONIC GADGETS IS NOTPERMITTED INSIDE THE EXAMINA TION HALL.
Define community?acquired methicillin resistant Staphylococcus aureus 5+5
(CA?MRSA). Discuss the changing epidemiology of CA?MRSA
infections in community and hospitals.
Enumerate the pathotypes of diarrheagenic Escherichia coli. Describe 3+7
the mechanism of diarrhoea caused by enteropathogenic E. coli.
Line probe assay (LPA) and its role in diagnosis and management of 5+5
tuberculosis.
Post?vaccination changing epidemiology of Streptococcus pneumoniae 5+5
infections. What are the available vaccines against Streptococcus
pneumoniae infections?
Enumerate etiological agents of genital discharges. Write in brief about 3+7
laboratory diagnosis of two of these agents.
Classify anaerobes. Write a short outline on pathogenesis and 2+3+5
laboratory diagnosis of gas gangrene.
Discuss the epidemiology of Candida auris infections. Enumerate the 5+5
distinctive characteristics of C. auris infections responsible for rapid
emergence of the pathogen.
Enumerate the types of pulmonary Aspergillosis. Discuss the laboratory 3+7
diagnosis of allergic bronchopulmonary aspergillosis.
Define and classify dermatophytes. What is the current status of drug 2+3+5
resistance in dermatophytes?
Current epidemiology and laboratory diagnosis of Cryptococcus 5+5
neoformans infections.
***************